Isbn: 9781402058882 - immunoregulation in inflammatory bowel diseases - current understanding and innovation (falk symposium, 153, band 153) (14 Ergebnisse)

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Zustand: Used. pp. xv + 210 1st Edition.

Zustand: Used. pp. xv + 210 Illus.

Zustand: Used. pp. xv + 210.

Zustand: New.

Zustand: New. In English.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand, new therapeutic options have emerged. These include modern immunomodulators, biologics, probiotics, worm eggs and extracorporeal therapies. The clinical relevance of these new modalities is often difficult to assess for physicians who do not work frequently with IBD patients.This book, the proceedings of the Falk Symposium No.153 on 'Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation', held May 6-7, 2006 in Berlin, Germany, critically discusses established and emerging new concepts in the diagnosis and treatment of IBD, reflecting the recent advancements in the aetiopathogenesis of these diseases. Controversial problems, such as the optimal therapeutic strategy (step-up versus top-down), therapy-associated side-effects and optimal control and selection of IBD therapies, are addressed by an internationally-renowned team of authors. The book will be essential reading for both basic scientists and clinicians.…

Hardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

hardcover. Zustand: Very Good. This volume from Falk Symposium 153 brings together leading international research on the immune mechanisms driving Crohnâs disease and ulcerative colitis. It examines cutting-edge findings in mucosal immunology, cytokine signalling, epithelial barrier function, and the complex interplay between genetics, microbiota, and host response. Contributors highlight emerging therapeutic strategies, from targeted biologics to innovative immunomodulatory approaches shaping the future of IBD treatment. A rigorous and authoritative reference for clinicians, researchers, and libraries specialising in gastroenterology, immunology, and inflammatory disease.…

Gebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Proceedings of the Falk Symposium 153 held in Berlin, Germany, May 6-7, 2006 |Interdisciplinary symposium bringing together basic science and clinical applicationsUp-to-date research findings at the highest scientific levelThis book con.…

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book contains the proceedings of the Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation, held May 2006 in Berlin, Germany. It critically discusses established and emerging new concepts in the diagnosis and treatment of IBD, reflecting the recent advancements in the aetiopathogenesis of these diseases. 236 pp. Englisch.…

Buch. Zustand: Neu. Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation | A. Dignass (u. a.) | Buch | xv | Englisch | 2007 | Springer | EAN 9781402058882 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. …

Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand, new therapeutic options have emerged. These include modern immunomodulators, biologics, probiotics, worm eggs and extracorporeal therapies. The clinical relevance of these new modalities is often difficult to assess for physicians who do not work frequently with IBD patients.This book, the proceedings of the Falk Symposium No.153 on ¿Immunoregulation in Inflammatory Bowel Diseases ¿ Current Understanding and Innovation¿, held May 6¿7, 2006 in Berlin, Germany, critically discusses established and emerging new concepts in the diagnosis and treatment of IBD, reflecting the recent advancements in the aetiopathogenesis of these diseases. Controversial problems, such as the optimal therapeutic strategy (step-up versus top-down), therapy-associated side-effects and optimal control and selection of IBD therapies, are addressed by an internationally-renowned team of authors. The book will be essential reading for both basic scientists and clinicians.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 236 pp. Englisch.…